MaxTack™ Device for Hernia Repair
(AFFIX Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team or your doctor for guidance.
The MaxTack™ Motorized Fixation Device is unique because it offers a motorized approach to securing mesh during hernia repair, potentially reducing the manual effort required compared to traditional tacking methods. This could lead to more consistent fixation and possibly less postoperative pain, addressing some of the drawbacks associated with permanent metallic tacks.
12345Eligibility Criteria
This trial is for individuals who need surgery to repair a ventral hernia, which is a bulge of tissues through an opening within abdominal muscles. Participants should be suitable candidates for minimally invasive surgical procedures.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Subjects treated with MaxTack™ Motorized Fixation Device for fixation of prosthetic material in minimally invasive ventral hernia repair
Short-term Follow-up
Participants are monitored for hernia recurrence and device performance within 1 to 3 months post-surgery
Long-term Follow-up
Participants are monitored for hernia recurrence and quality of life changes up to 12 months post-surgery
Participant Groups
MaxTack™ Motorized Fixation Device is already approved in United States for the following indications:
- Fixation of prosthetic material to soft tissue in minimally invasive ventral hernia repair procedures
- Fixation of prosthetic material to soft tissue in minimally invasive groin hernia repair procedures